Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 1863 entries
View as:

Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches

Phase: N/A Priority: Normal
NCT ID: NCT00600223 Org: User:
Start: 10/31/05 End: 10/31/10 Due: 10/31/11

Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00003755 Org: User:
Start: 10/31/98 End: 08/31/01 Due: 08/31/02

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00492999 Org: User:
Start: 05/31/07 End: 05/31/25 Due: 05/31/26

Single-agent Cobimetinib for Adults With Histiocytic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02649972 Org: User:
Start: 01/31/16 End: 12/16/22 Due: 12/16/23

Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Phase: N/A Priority: Normal
NCT ID: NCT00988169 Org: User:
Start: 09/30/09 End: 05/31/10 Due: 05/31/11

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Phase: N/A Priority: Normal
NCT ID: NCT02164019 Org: User:
Start: 06/30/14 End: 06/30/25 Due: 06/30/26

CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00020891 Org: User:
Start: 03/31/01 End: - Due: -

Biological Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002637 Org: User:
Start: 01/31/95 End: 02/28/01 Due: 02/28/02

A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure

Phase: N/A Priority: Normal
NCT ID: NCT03408366 Org: User:
Start: 01/15/18 End: 08/01/22 Due: 08/01/23

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01209598 Org: User:
Start: 09/23/10 End: 10/25/16 Due: 10/25/17

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Phase: N/A Priority: Normal
NCT ID: NCT01856543 Org: User:
Start: 05/31/13 End: 01/31/17 Due: 01/31/18

Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid

Phase: N/A Priority: Normal
NCT ID: NCT01349647 Org: User:
Start: 05/31/11 End: 07/31/15 Due: 07/31/16

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02673333 Org: User:
Start: 02/29/16 End: 02/28/26 Due: 02/28/27

Risk Stratification Among Individuals Who Have Many Moles on Their Skin

Phase: N/A Priority: Normal
NCT ID: NCT03080948 Org: User:
Start: 03/09/17 End: 03/31/26 Due: 03/31/27

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00024232 Org: User:
Start: 06/30/01 End: 02/29/04 Due: 02/28/05

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT05892068 Org: User:
Start: 05/09/23 End: 05/09/28 Due: 05/09/29

Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging

Phase: N/A Priority: Normal
NCT ID: NCT01473693 Org: User:
Start: 11/30/11 End: 01/31/14 Due: 01/31/15

Telemedicine Evaluation for Stem Cell Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT01324427 Org: User:
Start: 03/31/11 End: 08/31/20 Due: 08/31/21

Naxitamab and GM-CSF in People With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04501757 Org: User:
Start: - End: - Due: -

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01522768 Org: User:
Start: 03/31/12 End: 02/20/23 Due: 02/20/24

Rehabilitation of Cognitive Changes in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01182506 Org: User:
Start: 08/31/10 End: 08/31/25 Due: 08/31/26

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT02070575 Org: User:
Start: 02/20/14 End: 10/18/23 Due: 10/18/24

Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)

Phase: N/A Priority: Normal
NCT ID: NCT03010163 Org: User:
Start: 12/31/16 End: 06/30/25 Due: 06/30/26

Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02962063 Org: User:
Start: 11/30/16 End: 11/30/25 Due: 11/30/26

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01617174 Org: User:
Start: 06/30/12 End: 06/30/14 Due: 06/30/15